• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/65

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

65 Cards in this Set

  • Front
  • Back
Coronary Arteries ' Normal Anatomy:
Very first arteries coming off the aorta are the coronaries. Impacts the timing of coronary blood flow. As soon as LV ejects, blood goes to coronary arteries while contraction is still happening.
Basic Principles of ischemia/MI:
normal state oxygen extraction--
stenotic state oxygen extraction--
*Myocardial cells have to do only 2 things: contract and relax; BOTH are aerobic, energy requiring processes.

*Oxygen extraction in the coronary bed is MAXIMAL in the baseline state; therefore to increase O2 delivery, FLOW MUST INCREASE!

*Large visible epicardial arteries are conduit vessels not responsible for resistance to flow (when normal).

*Small, distal arterioles make up the major resistance to flow in the normal state.

*Atherosclerosis (an abnormal state) affects the proximal, large epicardial arteries.

*Once arteries are stenotic (narrowed) resistance to flow increases UNLESS distal, small arterioles are able to DILATE to COMPENSATE.
When does Myocardial Ischemia occur?
Discuss from a supply/demand of oxygen perspective--
Occurs when myocardial oxygen demand exceeds myocardial oxygen supply
Occurs when myocardial oxygen demand exceeds myocardial oxygen supply.
What determines MVO2? 3
*MVO2 = Myocardial Oxygen Demand.

*MVO2 determined by:
-Heart Rate
-Contractility
-Wall Tension
*MVO2 = Myocardial Oxygen Demand.

*MVO2 determined by:
-Heart Rate
-Contractility
-Wall Tension
What does MVO2 (Myocardial Oxygen Demand) increase with? 3
*Increases directly in proportion to heart rate.
*Increases with increased contractility.
*Increases with increased Wall Tension; i.e. increases with increasing preload or afterload.
Plot of MVO2 as a function of ∆ in HR:
*Linear relationship.
Plot of MVO2 as a function of ∆ in contractility:
*Y-intercept is shifted up compared to controls.
Discuss Wall Tension:
what is it?
equation for it?
what's it increased by?
*It's related to (Pressure x Radius)/(Wall thickness).

*Defined as: Force per unit area generated in the LV
throughout the cardiac cycle.

Increased by:
*Higher Afterload - LV systolic pressure
*Higher Preload - LV end-diastolic pressure or volume
Myocardial Oxygen Supply is Determined by:
Myocardial Oxygen Supply is Determined by:
*Increase in perfusion pressure increases flow.
*Resistance decreases it.
Coronary Blood Flow is Proportional to:
perfusion pressure / resistance
Coronary Blood Flow is Proportional to perfusion pressure / resistance.
Timing of Coronary Blood Flow:
*Most coronary blood flow occurs during diastole! This is why LVEDP = perfusion pressure.
Discuss Autoregulatory Resistance of coronary perfusion:
*Major component of resistance to flow.
*Locus is at arteriolar level.
*Adjusts flow to MVO2.

*Metabolic control of coronary perfusion is with:
-Oxygen
-Adenosine , ADP
-NO (nitric oxide)
-Lactate , H+ (pH)
-Histamine, Bradykinin
Autoregulatory Resistance: Describe the 3 different cells involved:
*Myocardial muscle cell - produces byproducts of aerobic metabolism (lactate, adenosine, etc).

*Vascular endothelial cell (arteriole) - reacts to metabolic byproducts.

*Vascular smooth muscle cell (arteriole) - SIGNALED by ENDOTHELIAL CELL to contract (vessel constriction) or relax (vessel dilation).
Autoregulation of Coronary Blood Flow: discuss roles of Oxygen and Adenosine--
*If you have enough O2, you don't need any more. Therefore, it's a constrictor.
*Adenosine is the most important. It has a really short (seconds) half life, so it's great as a messenger for rapid changes.
Discuss Adenosine's role during hypoxia:
*During hypoxemia, aerobic metabolism in mitochondria is inhibited.
*There is accumulation of ADP and AMP (from ATP).
*Production of adenosine--> breakdown product of aerobic metabolism.
*Adenosine vasodilates arterioles.
*Increased coronary blood flow.
Autoregulatory Resistance: plot of coronary perfusion pressure vs. flow:
*Adenosine gets clinically used to increase perfusion pressure.
What endothelial-derived factors contribute to autoregulation?
dilators--
constrictors--
Other endothelial- derived factors contribute to autoregulation
Dilators include:
EDRF (NO)
Prostacyclin
Constrictors include:
Endothelin-1
*Other endothelial- derived factors contribute to autoregulation:

*Dilators include:
1) EDRF (endothelial-derived relaxation factor: it's actually just NO)
2) Prostacyclin: increases cAMP.

*Constrictors include:
1) Endothelin-1; goes up during an MI.
Discuss Coronary Flow Reserve

How much can people increase their coronary blood flow?
*Arteriolar autoregulatory vasodilatory capacity in response to increased MVO2 or pharmacologic agents

*Expressed as a ratio of Maximum flow / Baseline flow:
~ 4-5 / 1 (experimentally...athletes/marathoners).

~ 2.25 - 3 (when measured clinically...normal people).
Discuss Coronary Flow Reserve during stenosis of vessels:

What is the critical level and what happens when you pass it?
*Stenosis in large epicardial (capacitance) vessel --> decreased perfusion pressure --> arterioles downstream dilate to maintain normal resting flow.

*As stenosis progresses, arteriolar dilation becomes chronic, decreasing potential to augment flow and thus decreasing CFR.

*Endocardial CFR < Epicardial CFR

*As CFR approaches 1.0 (vasodilatory capacity is “maxxed out”), any further decrease in Perfusion pressure OR increase in MVO2 results in ischemia.
Coronary Flow Reserve: what's the relationship of coronary blood flow to % diameter stenosis?
*75% before you really start to decrease flow.
*At ~90%, resting flow = maximal flow. This is the state where you can't move without pain.
*~95% = resting angina.
Endocardium and Coronary Flow Reserve:
in diastole:
in systole:
*Heart thickens in systole. Less blood flow to endocardium when this happens! Endocardial surface is most vulnerable part of the heart for this reason.
Compare Endocardium vs. Epicardium:
What factors make the endocardium vulnerable?
Endocardium:
*Greater shortening / thickening, higher wall tension: increased MVO2 in endocardium.

*Greater compressive resistance.

*Decreased Perfusion Pressure.

*Less collateral circulation.

*Net Result is more compensatory arteriolar vasodilatation at baseline and therefore DECREASED CFR.
Prevalence of CAD in Modern Society by age:
>40 = you pretty much have it.
Risk Factors for CAD:
*family History
*cigarette smoking (doubles risk)
*diabetes mellitus
*HTN
*hyperlipidemia (especially LDL)
*sedentary life-style (minor he says)
*obesity (minor he says)
*elevated homocysteine
*LP-a (lipoprotein a)
Coronary lesions in Men and Women with Westernized and non-Westernized diets:
*He points to LDL cholesterol as the culprit.
*Kyushu is a remote island in Japan.
Relationship between fat in diet and serum cholesterol:
*Different points = different countries.
Discuss the Atherosclerotic Plaque Evolution from Fatty Streak:
Fatty streaks present in young adults
Soft atherosclerotic plaques most vulnerable to fissuring/hemorrhage
Complex interaction  of substrate with circulating cells (platelets, macrophages) and neurohumoral factors
*Fatty streaks are present in young adults.
*Soft atherosclerotic plaques are most vulnerable to fissuring/hemorrhage.
*Complex interaction of substrate with circulating cells (platelets, macrophages) and neurohumoral factors.
Discuss the Plaque progression to the fibrous cap:
Fibrous cap develops when smooth muscle cells migrate to intima, producing a tough fibrous matrix which glues cells together
*Fibrous cap develops when smooth muscle cells migrate to intima, producing a tough fibrous matrix which glues cells together. More stable when there's a fibrous cap.
*Vessel remodeling = vessel outer wall expands to accommodate the plaque.
Intra-vascular Ultrasound (IVUS)
Intra-vascular Ultrasound (IVUS). White area is endothelial lining. These are normal vessels.
Atherosclerotic Plaque
Atherosclerotic Plaque. US on right side shows crescent shaped plaques (typical).
Physiologic Remodeling
*Physiologic Remodeling of arteries with plaques. Vessel wall is expanded outward.
*Angiogram doesn't show this. IVUS does.
Stable Angina - Describe Symptoms:
What makes it worse?
*Mid-substernal chest pain.
*Squeezing, pressure-like in quality (closed fist over chest = Levine’s sign). NOT SHARP!
*Builds to a peak and lasts 2-20 minutes.
*RADIATION to left arm, neck, jaw or back.
*Associated with SOB, sweating, or nau...
*Mid-substernal chest pain.
*Squeezing, pressure-like in quality (closed fist over chest = Levine’s sign). NOT SHARP!
*Builds to a peak and lasts 2-20 minutes.
*RADIATION to left arm, neck, jaw or back.
*Associated with SOB, sweating, or nausea.

*Exacerbated by exertion, cold, meals, or stress
relieved by rest, NTG. Things that increase MVO2!

*Why meals? Blood is going to the gut; it is shunted away from your heart. So if you have HD, don't go exercise after a meal.
WTF is going on here?
Stable Angina - Diagnosis Exercise Treadmill Test
*Stable Angina - Diagnosis Exercise Treadmill Test.
*Left: resting
*Middle shows ST depression with exercise.
Stable Angina - DiagnosisThallium Stress Test
*Stable Angina - Diagnosis with Thallium Stress Test
*Nuclear isotope shows decreased blood flow during exercise; less prominent at rest.
Stable Angina - Treatment
most important meds?
which ones decrease MVO2?
*Risk factor modification (HMG Co-A Reductase inhibitors = Statins)

*Aspirin--reduces platelet aggregation; less clot formation. BEST most important med.

*Decrease MVO2 with
-nitrates
-beta-blockers (really important too! Slow the HR and lower the BP!
-calcium channel blockers
-ACE-inhibitors

*Anti-oxidants (E, C, Folate, B6)? NO!!!! No evidence that they do anything.
Aspirin Therapy's effects on MI and death risk:
THE STUFF WORKS-- 81mg is sufficient.
Discuss treatment of Stable Angina with STENTS:
*Stent prevents artery from re-occluding.
*Right shows expanded vs. non-expanded stent.
*Chemical Coating inhibits cell growth.
Stable Angina - Treatment ; discuss Coronary Artery Bypass Grafting Surgery (CABG):
*One end sewed to aorta; one end sewed to coronary artery.
*Lasts 20-30 years. Left internal Mammary artery (LIMA) is used--for some reason, it doesn't develop atherosclerosis. No one knows why.
Schematic of an Unstable Plaque
*Schematic of an Unstable Plaque.
*Arrows indicate abnormal flow.
Unstable Plaque
Unstable Plaque. Note fissure, tissue factor causing thrombus --> angina and/or MI.
Cross section of a complicated plaque
Cross section of a complicated plaque. Note fissure and interplaque hemorrhage. Not that obstructive, but still killed the guy. This is autopsy specimen.
Angiogram in unstable angina:eccentric, ulcerated plaque
*Angiogram in unstable angina: eccentric, ulcerated plaque.
*Oval area is plaque. Clot is downstream of the plaque. Treat with stent!
Angiogram in unstable angina: after stent deployment
*Angiogram in unstable angina: after stent deployment.
*You can see the struts of the stent.
Acute Coronary Syndromes: discuss Terminology:
Pathophysiology of all 3 is the same:

*Unstable Angina (UA):
-ST depression, T Wave inversion or normal
-No enzyme release

*Non-ST elevation Myocardial Infarction (non-STEMI):
-ST depression, T Wave inversion or normal
-No Q waves
-CPK, LDH + Troponin release

*ST-elevation (“transmural”) Myocardial Infarction (STEMI):
ST elevation
+ Q waves
CPK, LDH + Troponin release
Discuss Pathophysiology of the Acute Coronary Syndromes (UA,MI):
*Plaque vulnerability and extrinsic triggers result in plaque rupture

*Platelet adherence, aggregation and activation of the coagulation cascade with polymerization of fibrin

*Thrombosis with sub-total or total coronary artery occlusion (if total --usually causing a “STEMI”)
Pathophysiology of Acute Coronary Syndromes
*activation and aggregation of platelets is important!
“Vulnerable Plaque”
“Vulnerable Plaque”
Coronary Stenosis Severity Prior to Myocardial Infarction:
*Actually, most MIs occur with <50% stenosis of lumen.
Discuss Acute Coronary Syndrome : Unstable Angina / non-STEMI Symptoms:
*new onset angina
*increase in frequency, duration or severity
*decrease in exertion required to provoke
*any prolonged episode (>10-15min)
*failure to abate with >2-3 SLNTG (nitro under tongue)
*onset at rest or awakening from sleep
Unstable Angina - Discuss High Risk Features:
*prolonged rest pain
*dynamic EKG changes (ST depression)
*age > 65
*diabetes mellitus
*left ventricular systolic dysfunction
*angina associated with congestive heart failure, new murmur, arrhythmias or hypotension
*elevated Troponin i or t
Unstable Angina / non-STEMI Pharmacologic Therapy:
*Anti-platelet therapy
-Aspirin
-Thienopyridine drugs (super aspirin)

*Heparin

*Decrease MVO2 with Nitrates, Beta-blockers, and ACE inhibitors

*consider platelet glycoprotein IIb / IIIa inhibitor and / or low molecular weight heparin

**Skipped all but the aspirin part**
Anti-Platelet Therapy

SKIPPED
Three principle pathways of platelet activation with >100 agonists: ( TXA2, ADP, Thrombin )
Final common pathway for platelet activation / aggregation involves membrane GP II b / III A receptor
Fibrinogen molecules cross-bridge receptor on adjacent platelets to form a scaffold for the hemostatic plug
Acute Myocardial Infarction

SKIPPED
*Total thrombotic occlusion of epicardial coronary artery  onset of ischemic cascade
prolonged ischemia  altered myocardial cell structure and eventual cell death (release of enzymes - CPK, LDH, Troponin)
altered structure  altered function (relaxation and contraction)
consequences of altered function often include exacerbation of ischemia (ischemia begets ischemia)
Discuss Acute Myocardial Infarction:
*wavefront phenomenon of ischemic evolution - endocardium to epicardium

*If limited area of infarction --> homeostasis achieved

*If large area of infarction (>20% LV )--> Congestive heart failure

*If larger area of infarction (>40% LV) --> hemodynamic collapse
SKIPPED
AMI - Wavefront Phenomenon
AMI - Wavefront Phenomenon
Acute Myocardial Infarction
SKIPPED
Cardiac enzymes: overview; HOW DO WE KNOW SOMEONE IS HAVING AN MI?
Legend:   A. Early CPK-MB isoforms after acute MI
	   B. Cardiac troponin after acute MI
	   C. CPK-MB after acute MI
	   D. Cardiac troponin after unstable angina
Legend:
A. Early CPK-MB isoforms after acute MI
B. Cardiac troponin after acute MI
C. CPK-MB after acute MI
D. Cardiac troponin after unstable angina

Troponin I is key.
Markers of MI: Discuss Troponin I:
*Pretty small molecule.
Diagnosis of MI: Discuss Role of troponin I:
Troponin I is highly sensitive
 Troponin I may be elevated after prolonged subendocardial ischemia
See examples below
*Troponin I is highly sensitive.

*Troponin I may be elevated after prolonged subendocardial ischemia.
Discuss Causes of Troponin elevation: 5
*Any cause of prolonged (>15 – 20 minutes) subendocardial ischemia:

-Prolonged angina pectoris.
-Prolonged tachycardia in setting of CAD.
-Congestive heart failure (elevated LVEDP causing decreased subendocardial perfusion).
-Hypoxia, coupled with CAD.
-“aborted” MI (lytic therapy or spontaneous clot lysis).
EKG diagnosis of MI

SKIPPED
Consequences of Ischemia (Ischemia begets Ischemia)

SKIPPED
*chest pain
*systolic dysfunction (loss of contraction)
*decrease cardiac output
*decrease coronary perfusion pressure
*diastolic dysfunction (loss of relaxation)
*higher pressure (PCWP) for any given volume
*dyspnea, decreased pO2, decreased O2 delivery
*increased wall tension (increased MVO2)

*All 3 give rise to stimulation of sympathetic nervous system with subsequent catecholamine release- increased heart rate and blood pressure (increased MVO2).
Ischemic Cycle

SKIPPED
Treatment of Acute Myocardial Infarction
SKIPPED
aspirin, thienopyridine, heparin, analgesia, oxygen
reperfusion therapy
cath lab (drug-coated or bare-metal stent)
thrombolytic therapy
decrease MVO2
nitrates, beta blockers and ACE inhibitors
for high PCWP - diuretics
for low Cardiac Output - pressors (dopamine, levophed, dobutamine); IABP; early catheterization
Thrombectomized material
*Thrombectomized material.
*About the size of fingernail clippings.